Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Goodwill & Intangibles: 2016-2024

Historic Goodwill & Intangibles for Collegium Pharmaceutical (COLL) over the last 8 years, with Dec 2024 value amounting to $1.1 billion.

  • Collegium Pharmaceutical's Goodwill & Intangibles fell 20.31% to $870.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $870.9 million, marking a year-over-year decrease of 20.31%. This contributed to the annual value of $1.1 billion for FY2024, which is 89.67% up from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Goodwill & Intangibles is $1.1 billion, which was up 89.67% from $555.6 million recorded in FY2023.
  • Collegium Pharmaceutical's Goodwill & Intangibles' 5-year high stood at $1.1 billion during FY2024, with a 5-year trough of $268.7 million in FY2021.
  • Its 3-year average for Goodwill & Intangibles is $770.2 million, with a median of $701.2 million in 2022.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first spiked by 1,038.54% in 2020, then dropped by 20.77% in 2023.
  • Over the past 5 years, Collegium Pharmaceutical's Goodwill & Intangibles (Yearly) stood at $335.9 million in 2020, then decreased by 20.00% to $268.7 million in 2021, then skyrocketed by 160.92% to $701.2 million in 2022, then fell by 20.77% to $555.6 million in 2023, then spiked by 89.67% to $1.1 billion in 2024.